BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9334174)

  • 1. Active site-directed inhibitors of Rhodococcus 20 S proteasome. Kinetics and mechanism.
    Mc Cormack T; Baumeister W; Grenier L; Moomaw C; Plamondon L; Pramanik B; Slaughter C; Soucy F; Stein R; Zühl F; Dick L
    J Biol Chem; 1997 Oct; 272(42):26103-9. PubMed ID: 9334174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic studies of the branched chain amino acid preferring peptidase activity of the 20S proteasome: development of a continuous assay and inhibition by tripeptide aldehydes and clasto-lactacystin beta-lactone.
    McCormack TA; Cruikshank AA; Grenier L; Melandri FD; Nunes SL; Plamondon L; Stein RL; Dick LR
    Biochemistry; 1998 May; 37(21):7792-800. PubMed ID: 9601040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin beta-lactone.
    Dick LR; Cruikshank AA; Grenier L; Melandri FD; Nunes SL; Stein RL
    J Biol Chem; 1996 Mar; 271(13):7273-6. PubMed ID: 8631740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation.
    Craiu A; Gaczynska M; Akopian T; Gramm CF; Fenteany G; Goldberg AL; Rock KL
    J Biol Chem; 1997 May; 272(20):13437-45. PubMed ID: 9148969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation of the sperm proteasome in human fertilization.
    Morales P; Kong M; Pizarro E; Pasten C
    Hum Reprod; 2003 May; 18(5):1010-7. PubMed ID: 12721178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells.
    Dick LR; Cruikshank AA; Destree AT; Grenier L; McCormack TA; Melandri FD; Nunes SL; Palombella VJ; Parent LA; Plamondon L; Stein RL
    J Biol Chem; 1997 Jan; 272(1):182-8. PubMed ID: 8995245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic characterization of the chymotryptic activity of the 20S proteasome.
    Stein RL; Melandri F; Dick L
    Biochemistry; 1996 Apr; 35(13):3899-908. PubMed ID: 8672420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 20S proteasome of Streptomyces coelicolor.
    Nagy I; Tamura T; Vanderleyden J; Baumeister W; De Mot R
    J Bacteriol; 1998 Oct; 180(20):5448-53. PubMed ID: 9765579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin.
    Fenteany G; Standaert RF; Lane WS; Choi S; Corey EJ; Schreiber SL
    Science; 1995 May; 268(5211):726-31. PubMed ID: 7732382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactacystin, a specific inhibitor of the proteasome, inhibits human platelet lysosomal cathepsin A-like enzyme.
    Ostrowska H; Wojcik C; Omura S; Worowski K
    Biochem Biophys Res Commun; 1997 May; 234(3):729-32. PubMed ID: 9175783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathiolation of the proteasome is enhanced by proteolytic inhibitors.
    Demasi M; Shringarpure R; Davies KJ
    Arch Biochem Biophys; 2001 May; 389(2):254-63. PubMed ID: 11339815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subunit topology of the Rhodococcus proteasome.
    Zühl F; Tamura T; Dolenc I; Cejka Z; Nagy I; De Mot R; Baumeister W
    FEBS Lett; 1997 Jan; 400(1):83-90. PubMed ID: 9000518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structures of the Rhodococcus proteasome with and without its pro-peptides: implications for the role of the pro-peptide in proteasome assembly.
    Kwon YD; Nagy I; Adams PD; Baumeister W; Jap BK
    J Mol Biol; 2004 Jan; 335(1):233-45. PubMed ID: 14659753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and localization of a cysteinyl residue critical for the trypsin-like catalytic activity of the proteasome.
    Dick LR; Moomaw CR; Pramanik BC; DeMartino GN; Slaughter CA
    Biochemistry; 1992 Aug; 31(32):7347-55. PubMed ID: 1510924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural investigation of proteasome inhibition.
    Ditzel L; Stock D; Löwe J
    Biol Chem; 1997; 378(3-4):239-47. PubMed ID: 9165077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first characterization of a eubacterial proteasome: the 20S complex of Rhodococcus.
    Tamura T; Nagy I; Lupas A; Lottspeich F; Cejka Z; Schoofs G; Tanaka K; De Mot R; Baumeister W
    Curr Biol; 1995 Jul; 5(7):766-74. PubMed ID: 7583123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why does threonine, and not serine, function as the active site nucleophile in proteasomes?
    Kisselev AF; Songyang Z; Goldberg AL
    J Biol Chem; 2000 May; 275(20):14831-7. PubMed ID: 10809725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat-shock protein 70 antisense oligomers enhance proteasome inhibitor-induced apoptosis.
    Robertson JD; Datta K; Biswal SS; Kehrer JP
    Biochem J; 1999 Dec; 344 Pt 2(Pt 2):477-85. PubMed ID: 10567231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent inhibitors of proteasome.
    Iqbal M; Chatterjee S; Kauer JC; Das M; Messina P; Freed B; Biazzo W; Siman R
    J Med Chem; 1995 Jun; 38(13):2276-7. PubMed ID: 7608891
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitors of the chymotrypsin-like activity of proteasome based on di- and tri-peptidyl alpha-keto aldehydes (glyoxals).
    Lynas JF; Harriott P; Healy A; McKervey MA; Walker B
    Bioorg Med Chem Lett; 1998 Feb; 8(4):373-8. PubMed ID: 9871688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.